Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
Instagram Outage Disrupts Thousands of U.S. Users 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
WALTHAM, Mass., Aug. 23, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in four upcoming investor conferences. The four conferences are:
- The Wells Fargo Global Healthcare Conference at the Westin Boston Waterfront in Boston on Wednesday, September 6. Tim Pearson, Executive Vice President and CFO of TESARO, is scheduled to present an overview of the Company’s business and development programs at 9:40 AM ET on September 6, and will also host meetings with investors.
- The 12th Annual Citi Biotech Day at the Mandarin Oriental Hotel in Boston on Wednesday, September 6 and Thursday, September 7, 2017. Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley, Ph.D., President and COO of TESARO, are scheduled to participate in an analyst-led fireside chat from 10:00 to 10:50 AM ET on Thursday, September 7, and will also host meetings with investors.
- The Baird 2017 Global Healthcare Conference at the InterContinental New York Barclay in New York City on Wednesday, September 6. Grant Bogle, Senior Vice President and Chief Commercial Officer of TESARO, is scheduled to participate in an analyst-led fireside chat from 9:40 to 10:10 AM ET on September 6, and will also host meetings with investors.
- The Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology at the Lotte New York Palace in New York City on Thursday, September 28, 2017. Lonnie Moulder and Mary Lynne Hedley, Ph.D. will participate in an analyst-led fireside chat from 1:00 to 1:55 PM ET, and in meetings with investors.
Live webcasts of the presentations at the Wells Fargo, Citi, Baird and Leerink Partners conferences will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company’s website for 14 days following the conferences.
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
For additional information, please contact: Jennifer Davis 1.781.325.1116 [email protected]
